Welcome to the e-CCO Library Archive!
P151
Ulcerative colitis patients with zinc deficiency are at higher risk for disease-related complications
S. S. Siva*1, D. T. Rubin1, G. Gulotta1, K. Wroblewski2, J. Pekow1
1The University of Chicago Inflammatory Bowel Disease Centre, Inflammatory Bowel Disease, Chicago, Illinois, United States, 2The University of Chicago, Public Health Sciences, Chicago, Illinois, United States
P152
Faecal calprotectin 100 ug/g and 50 ug/g predict endoscopic and histologic remission: a prospective study in quiescent ulcerative colitis
H. Y. Shi*, F. K. Chan, A. Higashimori, A. Chan, J. Y. Ching, J. C. Wu, J. J. Sung, S. C. Ng
The Chinese University of Hong Kong, Hong Kong, China
P153
Type of treating physician is associated with long-term disease outcome in the prospective Belgian paediatric Crohn’s disease registry
L. Wauters*1, F. Smets2, E. De Greef3, P. Bontems4, I. Hoffman5, B. Hauser3, P. Alliet6, W. Arts7, H. Peeters8, S. Van Biervliet9, I. Paquot10, E. Van de Vijver11, M. De Vos12, P. Bossuyt13, J.-F. Rahier14, O. Dewit15, T. Moreels15, D. Franchimont16, V. Muls16, F. Fontaine17, E. Louis17, J.-C. Coche18, J. Paul19, F. Baert20, S. Vermeire1, G. Veereman3
1UZ Leuven, Gastroenterology and Hepatology, Leuven, Belgium, 2UCL St Luc, Paediatric Gastroenterology, Brussels, Belgium, 3UZ Brussel, Paediatric Gastroenterology, Brussels, Belgium, 4HUDERF, Paediatric Gastroenterology, Brussels, Belgium, 5UZ Leuven, Paediatric Gastroenterology, Leuven, Belgium, 6Jessa ziekenhuis, Paediatric Gastroenterology, Hasselt, Belgium, 7ZOL Genk, Paediatric Gastroenterology, Genk, Belgium, 8ST Lucas, Gastroenterology, Ghent, Belgium, 9UZ Gent, Paediatric Gastroenterology, Ghent, Belgium, 10CHC Liège, Paediatric Gastroenterology, Liège, Belgium, 11UZ Antwerpen, Paediatric Gastroenterology, Antwerp, Belgium, 12UZ Gent, Gastroenterology, Ghent, Belgium, 13Imelda ziekenhuis, Gastroenterology, Bonheiden, Belgium, 14UCL Mont Godinne, Gastroenterology, Mont Godinne, Belgium, 15UCL St Luc, Gastroenterology, Brussels, Belgium, 16ULB Erasme, Gastroenterology, Brussels, Belgium, 17CHU Liège, Gastroenterology, Liège, Belgium, 18St Pierre, Gastroenterology, Ottignies, Belgium, 19DNA Lytics, Brussels, Belgium, 20Heilig Hart Ziekenhuis, Gastroenterology, Roeselaere, Belgium
P154
Temporal relationship of pregnancy to long-term disease course and pregnancy and foetal outcomes: North Indian inflammatory bowel disease cohort study
R. K. Padhan*1, S. Kumar1, S. Kedia1, R. Dhingra1, V. P. Mouli1, S. Bopanna1, S. Shrivastav1, L. Kurrey1, V. Sreenivas2, G. Makharia1, V. Ahuja1
1All India Institute of Medical Sciences, Gastroenterology, New Delhi, India, 2All India Institute of Medical Sciences, Statistics, New Delhi, India
P155
Thrombophilias and thromboembolic events in a population of patients with inflammatory bowel disease
J. Pinho*, D. Martins, P. Sousa, P. Ministro, E. Cancela, R. Araújo, A. Castanheira, A. Silva
Centro Hospitalar Tondela/Viseu, Viseu, Portugal
P156
Association between perinuclear anti-neutrophil cytoplasmic antibody status and clinical characteristics and outcomes of ulcerative colitis: a meta-analysis
H. J. Lee*1, J. J. Park2, H. J. Kim3
1Severance Hospital, Yonsei University College of Medicine, Internal Medicine, Seoul, South Korea, 2Gangnam Severance Hospital, Yonsei University College of Medicine, Internal Medicine, Seoul, South Korea, 3Korea University College of Medicine, Preventive Medicine, Seoul, South Korea
P157
Usefulness of, and factors influencing, the Ulcerative Colitis Endoscopic Index of Severity for the evaluation of short-term treatment response
K. Kawagishi*, K. Yokoyama, K. Kobayashi
Kitasato University School of Medicine, Gastroenterology, Sagamihara, Japan
P158
Comparison of 4L polyethylene glycol and 2L polyethylene glycol plus ascorbic acid in patients with inactive ulcerative colitis; randomised, single blind, multicentre study
E. S. Kim*1, B. I. Jang2, K. O. Kim2, E. Y. Kim3, S. W. Jeon4, H. S. Lee4, J. Heo4, Y. J. Lee1, H. J. Kim5
1Keimyung University School of Medicine, Internal Medicine, Daegu, South Korea, 2Yeungnam University College of Medicine, Internal Medicine, Daegu, South Korea, 3Catholic University of Daegu, Department of Internal Medicine, Daegu, South Korea, 4Kyungpook National University School of Medicine, Department of Internal Medicine, Daegu, South Korea, 5Gyeongsang National University School of Medicine, Internal Medicine, Jinju, South Korea
P159
The utility and benefit of procalcitonin to assess disease activity and severity in Crohn’s disease and intestinal Bechet disease
E. Hayashi, M. Saruta, S. Arihiro, M. Matsuoka, M. Mitsunaga, D. Ide, T. Iwasaki, M. Ogawa*, R. Sawada, Y. Nagata, T. Kato, H. Tajiri
The Jikei University School Of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokyo, Japan
P160
Do positive psychological factors affect the perception of health-related quality of life in inflammatory bowel disease patients?
M. Lozano Lanagran*1, L. Camacho Martel2, R. Camargo Camero2, J. Lopez Megias3, G. Alcain Martinez2
1Hospital Quiron, Malaga, Spain, 2Hospital Virgen de la Victoria, Malaga, Spain, 3Universidad de Granada, Granada, Spain
P161
Ultrasound as a primary imaging modality for follow-up of Crohn’s disease in pregnant women: initial results
A. Shitrit*1, A. Keinan2, B. Koslowsky3, E. Goldin3, K. R. Cytter4
1Shaare Zedek Medical Centre, Digestive Diseases Institute, Jerusalem, Israel, 2Shaare Zedek Medical Centre, Surgery Department, Jerusalem, Israel, 3Shaare Zedek Medical Centre, Digestive diseases institute, Jerusalem, Israel, 4Shaare Zedek Medical Centre, Radiology Department, Jerusalem, Israel
P162
Outcome of 114 patients admitted with acute severe ulcerative colitis over 5 years at a district general hospital
K. Wade, H. Johnson*, S. Weaver, S. McLaughlin
Royal Bournemouth Hospital, Department of Gastroenterology, Bournemouth, United Kingdom
P163
Assessment of the Inflammatory Bowel Disease Fatigue Patient Self-Assessment Scale in a Greek population of outpatients with IBD
I. Varbobitis, S. I. Siakavellas*, C. Kosmidis, I. Koutsounas, G. Bamias
Laikon Hospital, Academic Dpt. of Gastroenterology, Athens, Greece
P164
Which patients are at risk for clinical relapse in ulcerative colitis? A prospective study
P. Boal Carvalho*1, F. Dias de Castro1, M. Barbosa1, S. Monteiro1, T. Cúrdia Gonçalves1, B. Rosa1, M. J. Moreira1, J. Cotter1, 2, 3
1Hospital Senhora da Oliveira, Gastroenterology, Guimarães, Portugal, 2University of Minho, Life and Health Research Institute, Braga/Guimarães, Portugal, 3PT Government Associate Laboratory, ICVS/3B’s, Braga/Guimarães, Portugal
P165
Assessment of oxidative stress parameters for the disease activity evaluation in patients with ulcerative colitis
B. Canbakan*1, E. Koroglu1, K. Atay1, M. Tuncer1, H. Senturk2
1Istanbul University Cerrahpasa Medical School, Gastroenterology, Istanbul, Turkey, 2Bezmialem University School of Medicine, Gastroenterology, Istanbul, Turkey
P166
Venous thromboembolism with inflammatory bowel disease
L. Mouelhi*, O. Daboussi, M. Ben Khelifa, F. Houissa, K. El Jery, Y. Said, M. Salem, R. Dabbech, T. Najjar
Charles Nicolle Hospital, Gastroenterology, Tunis, Tunisia
P167
Real-world treatment persistence with vedolizumab in Crohn’s disease and ulcerative colitis patients
M. Raluy1, K. Fraeman2, R. Donaldson1, M. Reynolds3, M. Smyth4, D. Demuth4, J. M. Khalid*4
1Evidera, Hammersmith, United Kingdom, 2Evidera, Bethesda, United States, 3Evidera, Lexington, United States, 4Takeda, London, United Kingdom
P168
Interobserver agreement in bowel ultrasonography for diagnostic assessment in patients with Crohn’s disease
E. Calabrese*1, T. Kucharzik2, C. Maaser3, G. Maconi4, D. Strobel5, S. Wilson6, F. Zorzi7, K. Novak8, D. Bruining9, M. Iacucci8, M. Watanabe10, E. Lolli7, C. Chiaramonte7, S. Hanauer11, R. Panaccione8, F. Pallone7, S. Ghosh8
1University of Rome Tor Vergata, Gastroenterology Unit, Department of Systems Medicine, Rome, Italy, 2Department of Internal Medicine and Gastroenterology Staedtisches Klinikum, Luneburg, Germany, 3Ambulanzzentrum Gastroenterologie am Klinikum, Luneburg, Germany, 4Department of Clinical Sciences, L. Sacco University Hospital, Milan, Italy, 5University Hospital Erlangen, Erlangen, Germany, 6Division of Gastroenterology, Department of Medicine, University of Calgary,, Calgary, Canada, 7Gastroenterology Unit, Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy, 8Division of Gastroenterology, Department of Medicine, University of Calgary, Calgary, Canada, 9Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States, 10Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan, 11Northwestern University Feinberg School of Medicine, Digestive Disease Centre, Chicago, Illinois, United States
P169
A consensus of outcome measures to monitor and enhance the quality of an inflammatory bowel disease surgical service provision: results from a pan-European, multicentre, Delphi study
P. Morar*1, N. Sevdalis2, C. Edwards3, A. Hart1, W. Bemelman4, J. Warusavitarne1, O. Faiz1
1St Mark’s Hospital, Colorectal Surgery & IBD Unit, London, United Kingdom, 2Imperial College London, Surgery and Cancer, London, United Kingdom, 3Torbay Hospital, Gastroenterology, Torbay, United Kingdom, 4AMC, Surgery, Amsterdam, Netherlands
P170
Faecal osteoprotegerin correlates with disease activity and predicts disease relapse in paediatric inflammatory bowel disease
F. De Voogd*1, L. Burgess2, R. Gearry3, A. Day2
1University of Otago, Paediatrics/Gastroenterology, Christchurch, New Zealand, 2University of Otago, Paediatrics, Christchurch, New Zealand, 3University of Otago, Gastroenterology, Christchurch, New Zealand